Regeneron Pharmaceuticals (REGN) had the highest return in 2012 by a US stock with a market cap of $25B+, returning 202.7%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Regeneron Pharmaceuticals (REGN) | 2012 | 202.72% |
Alnylam Pharmaceuticals (ALNY) | 2012 | 119.09% |
Genmab A-S (GMAB) | 2012 | 114.07% |
Cheniere Energy (LNG) | 2012 | 111.25% |
Expedia (EXPE) | 2012 | 110.3% |
Bank of America (BAC) | 2012 | 102.89% |
Nomura Holdings Inc ADR (NMR) | 2012 | 100.4% |
Lloyds Banking Group PLC ADR (LYG) | 2012 | 97.54% |
Seagate Technology (STX) | 2012 | 90.71% |
Marathon Petroleum (MPC) | 2012 | 87.16% |
Illumina (ILMN) | 2012 | 79.32% |
Corpay (CPAY) | 2012 | 79.01% |
Gilead Sciences (GILD) | 2012 | 77.16% |
HCA Healthcare (HCA) | 2012 | 72.75% |
Sherwin-Williams (SHW) | 2012 | 72.3% |
Axon Enterprise (AXON) | 2012 | 70.61% |
NXP Semiconductors (NXPI) | 2012 | 66.79% |
Natwest (NWG) | 2012 | 66.25% |
eBay (EBAY) | 2012 | 65.42% |
Ferguson (FERG) | 2012 | 65.37% |
Valero Energy (VLO) | 2012 | 63.87% |
ICICI Bank (IBN) | 2012 | 63.32% |
ResMed (RMD) | 2012 | 62.85% |
PPG Industries (PPG) | 2012 | 62.2% |
Phillips 66 (PSX) | 2012 | 61.46% |